Endostar (rh‐endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non‐small cell lung cancer: A meta‐analysis

BACKGROUND: This meta‐analysis was conducted to investigate the efficacy and safety of Endostar (rh‐endostatin) versus a placebo in combination with a vinorelbine plus cisplatin (NP) chemotherapy regimen for the treatment of advanced non‐small cell lung cancer (NSCLC). METHODS: Two reviewers indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Jihong, Lv, Weiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928372/
https://www.ncbi.nlm.nih.gov/pubmed/29575575
http://dx.doi.org/10.1111/1759-7714.12626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928372/
https://www.ncbi.nlm.nih.gov/pubmed/29575575
http://dx.doi.org/10.1111/1759-7714.12626

Ejemplares similares